• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Simultaneous detection by consensus multiplex PCR of high- and low-risk and other types of human papilloma virus in clinical samples.

作者信息

Zheng P S, Li S R, Iwasaka T, Song J, Cui M H, Sugimori H

机构信息

Department of Obstetrics and Gynecology, Second Teaching Hospital, Norman Bethune University of Medical Sciences, Changchun, People's Republic of China.

出版信息

Gynecol Oncol. 1995 Aug;58(2):179-83. doi: 10.1006/gyno.1995.1206.

DOI:10.1006/gyno.1995.1206
PMID:7622102
Abstract

A consensus multiplex PCR (CM-PCR) technique was developed to detect high-risk (HPV 16/18), low-risk (HPV 6/11), and over 40 other types of human papillomavirus (HPV), separately but simultaneously, by mixing three pairs of consensus primers in the same PCR mixture, for gene amplification. Simultaneous detection of three groups of HPV DNA provides valuable information for clinical practice and this procedure is simple and convenient for routine laboratory examinations. We detected HPV DNA sequences in plasmid HPV DNA and DNA extracted from tissues of condyloma acuminata and cervical carcinoma and from exfoliated cells of the lower genital tract of healthy Chinese women living in the People's Republic of China. We confirmed that this simple, convenient, and cost-beneficial CM-PCR technique is reliable for the detection of HPV DNA sequences.

摘要

相似文献

1
Simultaneous detection by consensus multiplex PCR of high- and low-risk and other types of human papilloma virus in clinical samples.
Gynecol Oncol. 1995 Aug;58(2):179-83. doi: 10.1006/gyno.1995.1206.
2
Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.用于聚合酶链反应检测人乳头瘤病毒的人乳头瘤病毒通用引物的评估
Mol Cell Probes. 1999 Feb;13(1):9-21. doi: 10.1006/mcpr.1998.0203.
3
Human papillomavirus detection in cervical carcinoma tissues and paraaortic lymph nodes by the polymerase chain reaction.通过聚合酶链反应检测宫颈癌组织和主动脉旁淋巴结中的人乳头瘤病毒
Gynecol Oncol. 1994 Jun;53(3):344-51. doi: 10.1006/gyno.1994.1145.
4
[Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].子宫颈病变与人乳头瘤病毒感染(HPV):使用聚合酶链反应(PCR)检测和鉴定DNA/HPV
Acta Med Port. 2000 Jul-Aug;13(4):181-92.
5
[Human papilloma virus infection in vaginal condyloma acuminatum].[阴道尖锐湿疣中的人乳头瘤病毒感染]
Rinsho Byori. 2003 Feb;51(2):93-7.
6
[Detection of human papillomavirus DNA in cervical squamous cell carcinoma in Xinjiang Uygur women].[新疆维吾尔族女性宫颈鳞状细胞癌中人乳头瘤病毒DNA的检测]
Zhonghua Fu Chan Ke Za Zhi. 1997 Jul;32(7):405-8.
7
Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.使用实时聚合酶链反应分析对ThinPrep巴氏试验剩余材料中的人乳头瘤病毒16 E6和E7 DNA及RNA进行定量分析。
Cancer. 2002 Apr 15;94(8):2199-210. doi: 10.1002/cncr.10439.
8
HPV detection in cervical cancer patients in northern Poland.波兰北部宫颈癌患者的人乳头瘤病毒检测
Oncol Rep. 2002 Jul-Aug;9(4):871-4.
9
[Estimation of HPV infection presence in cytological smears in a group of asymptomatic women].[一组无症状女性细胞学涂片中人乳头瘤病毒(HPV)感染情况的评估]
Wiad Lek. 2001;54(9-10):508-15.
10
Polymerase chain reaction. A sensitive indicator of the prevalence of human papillomavirus DNA in a population with sexually transmitted disease.聚合酶链反应。一种在性传播疾病人群中人类乳头瘤病毒DNA流行率的敏感指标。
Acta Cytol. 1995 Jul-Aug;39(4):654-8.

引用本文的文献

1
A role for arrays in clinical virology: fact or fiction?阵列技术在临床病毒学中的作用:事实还是虚构?
J Clin Virol. 2004 Jan;29(1):2-12. doi: 10.1016/j.jcv.2003.08.002.
2
Multiplex PCR: optimization and application in diagnostic virology.多重聚合酶链反应:诊断病毒学中的优化与应用
Clin Microbiol Rev. 2000 Oct;13(4):559-70. doi: 10.1128/CMR.13.4.559.